{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T10:26:40Z","timestamp":1785407200683,"version":"3.56.0"},"reference-count":42,"publisher":"BMJ","issue":"3","license":[{"start":{"date-parts":[[2024,3,13]],"date-time":"2024-03-13T00:00:00Z","timestamp":1710288000000},"content-version":"unspecified","delay-in-days":12,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["INV-053846"],"award-info":[{"award-number":["INV-053846"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2024,2,19]]},"published-print":{"date-parts":[[2024,3]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>\n                      Seasonal malaria chemoprevention (SMC) involves repeated administrations of sulfadoxine-pyrimethamine plus amodiaquine to children below the age of 5 years during the peak transmission season in areas of seasonal malaria transmission. While highly impactful in reducing\n                      <jats:italic>Plasmodium falciparum<\/jats:italic>\n                      malaria burden in controlled research settings, the impact of SMC on infection prevalence is moderate in real-life settings. It remains unclear what drives this efficacy decay. Recently, the WHO widened the scope for SMC to target all vulnerable populations. The Ministry of Health (MoH) in Burkina Faso is considering extending SMC to children below 10 years old. We aim to assess the impact of SMC on clinical incidence and parasite prevalence and quantify the human infectious reservoir for malaria in this population.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and analysis<\/jats:title>\n                    <jats:p>We will perform a cluster randomised trial in Sapon\u00e9 Health District, Burkina Faso, with three study arms comprising 62 clusters of three compounds: arm 1 (control): SMC in under 5-year-old children, implemented by the MoH without directly observed treatment (DOT) for the full course of SMC; arm 2 (intervention): SMC in under 5-year-old children, with DOT for the full course of SMC; arm 3 (intervention): SMC in under 10-year-old children, with DOT for the full course of SMC. The primary endpoint is parasite prevalence at the end of the malaria transmission season. Secondary endpoints include the impact of SMC on clinical incidence. Factors affecting SMC uptake, treatment adherence, drug concentrations, parasite resistance markers and transmission of parasites will be determined.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Ethics and dissemination<\/jats:title>\n                    <jats:p>The London School of Hygiene &amp; Tropical Medicine\u2019s Ethics Committee (29193) and the Burkina Faso National Medical Ethics Committee (Deliberation No 2023-05-104) approved this study. The findings will be presented to the community; disease occurrence data and study outcomes will also be shared with the Burkina Faso MoH. Findings will be published irrespective of their results.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration number<\/jats:title>\n                    <jats:p>\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"clintrialgov\" xlink:href=\"NCT05878366\">NCT05878366<\/jats:ext-link>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2023-081682","type":"journal-article","created":{"date-parts":[[2024,3,13]],"date-time":"2024-03-13T01:51:32Z","timestamp":1710294692000},"page":"e081682","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":1,"title":["Understanding and maximising the community impact of seasonal malaria chemoprevention in Burkina Faso (INDIE-SMC): study protocol for a cluster randomised evaluation trial"],"prefix":"10.1136","volume":"14","clinical-trial-number":[{"clinical-trial-number":"nct05878366","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9091-5612","authenticated-orcid":false,"given":"Marta","family":"Moreno","sequence":"first","affiliation":[{"name":"Department of Infection Biology, London School of Hygiene & Tropical Medicine, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aissata","family":"Barry","sequence":"additional","affiliation":[{"name":"Groupe de Recherche Action en Sant\u00e9, Ouagadougou, Burkina Faso"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Gmeiner","sequence":"additional","affiliation":[{"name":"Department of Medical Microbiology, Radboud University Nijmegen, Nijmegen, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean Baptist","family":"Yaro","sequence":"additional","affiliation":[{"name":"Groupe de Recherche Action en Sant\u00e9, Ouagadougou, Burkina Faso"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel S","family":"Serm\u00e9","sequence":"additional","affiliation":[{"name":"Groupe de Recherche Action en Sant\u00e9, Ouagadougou, Burkina Faso"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"Byrne","sequence":"additional","affiliation":[{"name":"Department of Infection Biology, London School of Hygiene & Tropical Medicine, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordache","family":"Ramjith","sequence":"additional","affiliation":[{"name":"Department of Medical Microbiology, Radboud University Nijmegen, Nijmegen, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alphonse","family":"Ouedraogo","sequence":"additional","affiliation":[{"name":"Groupe de Recherche Action en Sant\u00e9, Ouagadougou, Burkina Faso"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Issiaka","family":"Soulama","sequence":"additional","affiliation":[{"name":"Groupe de Recherche Action en Sant\u00e9, Ouagadougou, Burkina Faso"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynn","family":"Grignard","sequence":"additional","affiliation":[{"name":"Department of Infection Biology, London School of Hygiene & Tropical Medicine, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyi","family":"Soremekun","sequence":"additional","affiliation":[{"name":"Department of Infection Biology, London School of Hygiene & Tropical Medicine, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Koele","sequence":"additional","affiliation":[{"name":"Department of Medical Microbiology, Radboud University Nijmegen, Nijmegen, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rob","family":"ter Heine","sequence":"additional","affiliation":[{"name":"Pharmacy, Radboudumc, Nijmegen, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amidou Z","family":"Ouedraogo","sequence":"additional","affiliation":[{"name":"Groupe de Recherche Action en Sant\u00e9, Ouagadougou, Burkina Faso"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean","family":"Sawadogo","sequence":"additional","affiliation":[{"name":"Groupe de Recherche Action en Sant\u00e9, Ouagadougou, Burkina Faso"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edith","family":"Sanogo","sequence":"additional","affiliation":[{"name":"Groupe de Recherche Action en Sant\u00e9, Ouagadougou, Burkina Faso"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Issa N","family":"Ouedraogo","sequence":"additional","affiliation":[{"name":"Groupe de Recherche Action en Sant\u00e9, Ouagadougou, Burkina Faso"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denise","family":"Hien","sequence":"additional","affiliation":[{"name":"Groupe de Recherche Action en Sant\u00e9, Ouagadougou, Burkina Faso"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sodiomon Bienvenu","family":"Sirima","sequence":"additional","affiliation":[{"name":"Groupe de Recherche Action en Sant\u00e9, Ouagadougou, Burkina Faso"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Bradley","sequence":"additional","affiliation":[{"name":"Department of Infection Biology, London School of Hygiene & Tropical Medicine, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teun","family":"Bousema","sequence":"additional","affiliation":[{"name":"Department of Medical Microbiology, Radboud University Nijmegen, Nijmegen, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Drakeley","sequence":"additional","affiliation":[{"name":"Department of Infection Biology, London School of Hygiene & Tropical Medicine, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfred B","family":"Tiono","sequence":"additional","affiliation":[{"name":"Groupe de Recherche Action en Sant\u00e9, Ouagadougou, Burkina Faso"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2024,3,12]]},"reference":[{"key":"2025121407490325000_14.3.e081682.1","unstructured":"Organization WH . World malaria report 2022. Contract no.: CC BY-NC-SA 3.0 IGO; 2022."},{"key":"2025121407490325000_14.3.e081682.2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc1713777"},{"key":"2025121407490325000_14.3.e081682.3","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)32227-3"},{"key":"2025121407490325000_14.3.e081682.4","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/S2352-4642(20)30127-9","article-title":"Treatment and prevention of malaria in children","volume":"4","author":"Ashley","year":"2020","journal-title":"Lancet Child Adolesc Health"},{"key":"2025121407490325000_14.3.e081682.5","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003727","article-title":"Effectiveness of seasonal malaria chemoprevention (SMC) treatments when SMC is implemented at scale: case-control studies in 5 countries","volume":"18","author":"Cairns","year":"2021","journal-title":"PLoS Med"},{"key":"2025121407490325000_14.3.e081682.6","unstructured":"Organization WH . Updated WHO recommendations for malaria chemoprevention among children and pregnant women. Geneva, Switzerland World Health Organization; 2022."},{"key":"2025121407490325000_14.3.e081682.7","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002175","article-title":"Effectiveness of seasonal malaria chemoprevention in children under ten years of age in Senegal: a stepped-wedge cluster-randomised trial","volume":"13","author":"Ciss\u00e9","year":"2016","journal-title":"PLoS Med"},{"key":"2025121407490325000_14.3.e081682.8","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002456","article-title":"malERA: an updated research agenda for health systems and policy research in malaria elimination and eradication","volume":"14","author":"Rabinovich","year":"2017","journal-title":"PLoS Med"},{"key":"2025121407490325000_14.3.e081682.9","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1002\/cpt.1707","article-title":"Adherence and population pharmacokinetic properties of amodiaquine when used for seasonal malaria chemoprevention in African children","volume":"107","author":"Ding","year":"2020","journal-title":"Clin Pharmacol Ther"},{"key":"2025121407490325000_14.3.e081682.10","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1056\/NEJMoa2026330","article-title":"Seasonal malaria vaccination with or without seasonal malaria chemoprevention","volume":"385","author":"Chandramohan","year":"2021","journal-title":"N Engl J Med"},{"key":"2025121407490325000_14.3.e081682.11","doi-asserted-by":"crossref","unstructured":"Collins K , Ouedraogo A , Guelbeogo MW , et al . Active screening and treatment significantly reduces the infectious reservoir of malaria in Burkina Faso: results from a randomised trial. SSRN [Preprint] 2023. doi:10.2139\/ssrn.4585247","DOI":"10.2139\/ssrn.4585247"},{"key":"2025121407490325000_14.3.e081682.12","doi-asserted-by":"crossref","unstructured":"Soremekun S , Conteh B , Nyassi A , et al . Household-level effects of seasonal malaria chemoprevention in the gambia. In Review [Preprint] 2023. doi:10.21203\/rs.3.rs-3228680\/v1","DOI":"10.21203\/rs.3.rs-3228680\/v1"},{"key":"2025121407490325000_14.3.e081682.13","doi-asserted-by":"publisher","DOI":"10.1016\/j.pt.2013.08.002"},{"key":"2025121407490325000_14.3.e081682.14","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S1473-3099(22)00593-X","article-title":"Prevalence of plasmodium falciparum haplotypes associated with resistance to sulfadoxine-pyrimethamine and amodiaquine before and after upscaling of seasonal malaria chemoprevention in seven African countries: a genomic surveillance study","volume":"23","author":"Beshir","year":"2023","journal-title":"Lancet Infect Dis"},{"key":"2025121407490325000_14.3.e081682.15","doi-asserted-by":"crossref","DOI":"10.1186\/s12936-023-04488-4","article-title":"A non-randomized controlled trial to assess the protective effect of SMC in the context of high parasite resistance in Uganda","volume":"22","author":"Nuwa","year":"2023","journal-title":"Malar J"},{"key":"2025121407490325000_14.3.e081682.16","doi-asserted-by":"crossref","DOI":"10.1186\/s12936-020-03553-6","article-title":"Pharmacokinetic profile of amodiaquine and its active metabolite desethylamodiaquine in Ghanaian patients with uncomplicated Falciparum malaria","volume":"20","author":"Anyorigiya","year":"2021","journal-title":"Malar J"},{"key":"2025121407490325000_14.3.e081682.17","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00875-06"},{"key":"2025121407490325000_14.3.e081682.18","doi-asserted-by":"publisher","DOI":"10.1086\/503051"},{"key":"2025121407490325000_14.3.e081682.19","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1093\/infdis\/jiaa157","article-title":"A randomized clinical trial to compare plasmodium falciparum gametocytemia and infectivity after blood-stage or mosquito bite-induced controlled malaria infection","volume":"224","author":"Alkema","year":"2021","journal-title":"J Infect Dis"},{"key":"2025121407490325000_14.3.e081682.20","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(18)30044-6"},{"key":"2025121407490325000_14.3.e081682.21","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpara.2010.05.004"},{"key":"2025121407490325000_14.3.e081682.22","doi-asserted-by":"crossref","unstructured":"Mahamar A , Smit M , Sanogo K , et al . n.d. Artemether-lumefantrine with or without single-dose primaquine and sulfadoxine-pyrimethamine plus amodiaquine with or without single-dose tafenoquine to reduce plasmodium falciparum transmission: a phase 2 single-blind randomised clinical trial in Ouelessebougou, Mali. Ancet Microbe, Accepted for Publication 2024","DOI":"10.1101\/2024.02.27.24303370"},{"key":"2025121407490325000_14.3.e081682.23","doi-asserted-by":"publisher","DOI":"10.1016\/s1473-3099(21)00072-4"},{"key":"2025121407490325000_14.3.e081682.24","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-017-01270-4","article-title":"Examining the human infectious reservoir for plasmodium falciparum malaria in areas of differing transmission intensity","volume":"8","author":"Gon\u00e7alves","year":"2017","journal-title":"Nat Commun"},{"key":"2025121407490325000_14.3.e081682.25","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1093\/infdis\/jiac169","article-title":"Asymptomatic school-aged children are important drivers of malaria transmission in a high endemicity setting in Uganda","volume":"226","author":"Rek","year":"2022","journal-title":"J Infect Dis"},{"key":"2025121407490325000_14.3.e081682.26","doi-asserted-by":"crossref","first-page":"e668","DOI":"10.1016\/S2214-109X(18)30126-8","article-title":"Assessment of community-level effects of intermittent preventive treatment for malaria in schoolchildren in Jinja, Uganda (START-IPT trial): a cluster-randomised trial","volume":"6","author":"Staedke","year":"2018","journal-title":"Lancet Glob Health"},{"key":"2025121407490325000_14.3.e081682.27","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.32625","article-title":"Variation in natural exposure to anopheles mosquitoes and its effects on malaria transmission","volume":"7","author":"Guelb\u00e9ogo","year":"2018","journal-title":"Elife"},{"key":"2025121407490325000_14.3.e081682.28","doi-asserted-by":"crossref","first-page":"e1499","DOI":"10.1016\/S2214-109X(20)30325-9","article-title":"Preventive malaria treatment among school-aged children in sub-Saharan Africa: a systematic review and meta-analyses","volume":"8","author":"Cohee","year":"2020","journal-title":"Lancet Glob Health"},{"key":"2025121407490325000_14.3.e081682.29","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001942","article-title":"'Asymptomatic' malaria: a chronic and debilitating infection that should be treated","volume":"13","author":"Chen","year":"2016","journal-title":"PLoS Med"},{"key":"2025121407490325000_14.3.e081682.30","unstructured":"World Health Organisation . Updated WHO recommendations for malaria chemoprevention among children and pregnant women; 2022."},{"key":"2025121407490325000_14.3.e081682.31","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-158-3-201302050-00583"},{"key":"2025121407490325000_14.3.e081682.32","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2019-030598","article-title":"Investigating the impact of enhanced community case management and monthly screening and treatment on the transmissibility of malaria infections in Burkina Faso: study protocol for a cluster-randomised trial","volume":"9","author":"Collins","year":"2019","journal-title":"BMJ Open"},{"key":"2025121407490325000_14.3.e081682.33","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-021-22573-7","article-title":"Higher gametocyte production and mosquito infectivity in chronic compared to incident plasmodium falciparum infections","volume":"12","author":"Barry","year":"2021","journal-title":"Nat Commun"},{"key":"2025121407490325000_14.3.e081682.34","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.34463","article-title":"Predicting the likelihood and intensity of mosquito infection from sex specific plasmodium falciparum gametocyte density","volume":"7","author":"Bradley","year":"2018","journal-title":"Elife"},{"key":"2025121407490325000_14.3.e081682.35","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1093\/cid\/ciz134","article-title":"Transmission-blocking effects of primaquine and methylene blue suggest plasmodium falciparum gametocyte sterilization rather than effects on sex ratio","volume":"69","author":"Bradley","year":"2019","journal-title":"Clin Infect Dis"},{"key":"2025121407490325000_14.3.e081682.36","doi-asserted-by":"crossref","first-page":"e336","DOI":"10.1016\/S2666-5247(21)00356-6","article-title":"Single low-dose tafenoquine combined with dihydroartemisinin-piperaquine to reduce plasmodium falciparum transmission in ouelessebougou, Mali: a phase 2, single-blind, randomised clinical trial","volume":"3","author":"Stone","year":"2022","journal-title":"Lancet Microbe"},{"key":"2025121407490325000_14.3.e081682.37","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.899615","article-title":"Quantifying reductions in plasmodium falciparum infectivity to mosquitos: a sample size calculator to inform clinical trials on transmission-reducing interventions","volume":"13","author":"Ramjith","year":"2022","journal-title":"Front Immunol"},{"key":"2025121407490325000_14.3.e081682.38","doi-asserted-by":"publisher","DOI":"10.1016\/j.molbiopara.2004.03.018"},{"key":"2025121407490325000_14.3.e081682.39","doi-asserted-by":"crossref","DOI":"10.1186\/s12936-018-2584-y","article-title":"A multiplex assay for the sensitive detection and quantification of male and female plasmodium falciparum gametocytes","volume":"17","author":"Meerstein-Kessel","year":"2018","journal-title":"Malar J"},{"key":"2025121407490325000_14.3.e081682.40","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.47.4.1347-1354.2003"},{"key":"2025121407490325000_14.3.e081682.41","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1093\/infdis\/jiad172","article-title":"Seasonal malaria chemoprevention drug levels and drug resistance markers in children with or without malaria in Burkina Faso: a case-control study","volume":"228","author":"Roh","year":"2023","journal-title":"J Infect Dis"},{"key":"2025121407490325000_14.3.e081682.42","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.930956","article-title":"The acquisition of humoral immune responses targeting plasmodium falciparum sexual stages in controlled human malaria infections","volume":"13","author":"de Jong","year":"2022","journal-title":"Front Immunol"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2023-081682","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,14]],"date-time":"2025-12-14T15:49:09Z","timestamp":1765727349000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2023-081682"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":42,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2024,3,12]]},"published-print":{"date-parts":[[2024,3]]}},"alternative-id":["10.1136\/bmjopen-2023-081682"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2023-081682","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3]]}}}